دارویی اسوه
داسوه | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/04/18 Fiscal Year 2025/12/2112 Month | 2025/03/10 Fiscal Year 2024/12/2012 Month | 2024/03/13 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 183.207 Billion | 137.888 Billion | 460.121 Billion | |
Trade Receivables | 12.066 Trillion | 10.565 Trillion | 8.585 Trillion | |
Prepayments | 410.376 Billion | 265.285 Billion | 1.094 Trillion | |
Raw Materials & Packaging Inventory | 1.051 Trillion | 1.34 Trillion | 1.627 Trillion | |
Work-in-Progress Inventory | 77.83 Billion | 41.127 Billion | 193.371 Billion | |
Finished Goods Inventory | 239.52 Billion | 191.32 Billion | 675.628 Billion | |
Spare Parts Inventory | 153.74 Billion | 147.815 Billion | 130.901 Billion | |
Goods in Transit | - | - | 331.625 Billion | |
Our Goods on Consignment with Others | 8.246 Billion | 5.492 Billion | 7.899 Billion | |
Other Inventories | 17.743 Billion | 13.325 Billion | 6.055 Billion | |
Inventories | 1.548 Trillion | 1.739 Trillion | 2.972 Trillion | |
Total Current Assets | 14.208 Trillion | 12.708 Trillion | 13.112 Trillion | |
Long-Term Investments | 191.377 Billion | 360.653 Billion | 123.377 Billion | |
Long-Term Investments in Affiliates | 169.276 Billion | - | 168.762 Billion | |
Long-Term Trade Receivables | 26.003 Billion | 4.108 Billion | 5.877 Billion | |
Intangible Assets | 2.621 Billion | 2.067 Billion | 6.879 Billion | |
Property, Plant & Equipment | 1.409 Trillion | 1.399 Trillion | 1.384 Trillion | |
Net Fixed Assets | 1.409 Trillion | 1.399 Trillion | 1.384 Trillion | |
Total Non-Current Assets | 1.798 Trillion | 1.766 Trillion | 1.688 Trillion | |
Total Assets | 16.006 Trillion | 14.474 Trillion | 14.801 Trillion | |
Trade Payables | 3.07 Trillion | 3.091 Trillion | 1.907 Trillion | |
Income Tax Provision | 899.17 Billion | 361.306 Billion | 581.434 Billion | |
Proposed & Payable Dividends | 3.602 Trillion | 3.817 Trillion | 3.533 Trillion | |
Current Borrowings | 1.154 Trillion | 2.912 Trillion | 3.657 Trillion | |
Total Current Liabilities | 8.726 Trillion | 10.182 Trillion | 9.678 Trillion | |
Long-Term Borrowings | 1.067 Trillion | - | - | |
Employee Termination Benefits Provision | 559.863 Billion | 414.115 Billion | 302.03 Billion | |
Total Non-Current Liabilities | 1.627 Trillion | 414.115 Billion | 302.03 Billion | |
Total Liabilities | 10.353 Trillion | 10.596 Trillion | 9.98 Trillion | |
Capital | 750 Billion | 750 Billion | 750 Billion | |
Retained Earnings | 4.843 Trillion | 3.079 Trillion | 4.026 Trillion | |
Legal Reserve | 75 Billion | 75 Billion | 75 Billion | |
Share Premium Reserve | -14.265 Billion | -25.561 Billion | -30 Billion | |
Total Equity | 5.653 Trillion | 3.878 Trillion | 4.821 Trillion | |
Total Liabilities & Equity | 16.006 Trillion | 14.474 Trillion | 14.801 Trillion | |
Approved Capital | 750 Billion | 750 Billion | 750 Billion | |
Approved Retained Earnings | 3.493 Trillion | 3.079 Trillion | 3.051 Trillion | |
Approved Legal Reserve | 75 Billion | 75 Billion | 75 Billion | |
Total Approved Equity (at AGM) | 4.318 Trillion | 3.904 Trillion | 3.876 Trillion |